LL-37 · Antimicrobial peptide research context

LL-37 is a naturally occurring peptide described in the scientific literature as a member of the cathelicidin family of host-defense (antimicrobial) peptides found in humans. It has been studied in laboratory and research settings for its role in innate immune signaling.

This page is provided for educational purposes only. It does not describe dosing, does not make treatment or outcome claims, and does not present LL-37 as a therapy for any condition. Whether any peptide is appropriate for an individual is a determination made only by a licensed provider following a confidential intake and review.

In the research literature, LL-37 is characterized in the context of innate immune defense and interactions with microbial membranes and immune-signaling components in laboratory models. Investigators have described these properties within research settings rather than as clinical outcome claims.

Mechanistic descriptions in the literature are drawn from laboratory and early-stage research and should not be interpreted as evidence of clinical benefit. The relationship between any described mechanism and real-world outcomes in people has not been established here and remains a matter for qualified researchers and licensed providers to evaluate.

Regulatory status varies by country and can change. LL-37 is studied in research contexts, and its legal and regulatory classification differs across jurisdictions. Nothing on this page should be read as a claim of approval, safety, or efficacy.

Education only · provider review required. A licensed provider determines whether any peptide is appropriate for an individual after a confidential intake.